Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2527254 | 0.93 | NAAA (0.52) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL28543299 | 0.91 | NAAA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL28494279 | 0.91 | NAAA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL2525587 | 0.91 | NAAA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| Butyl Alcohol SCHEMBL7775027 | 0.91 | DGKA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL7267842 | 0.91 | NAAA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL2526191 | 0.91 | NAAA (0.55) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL2251062 | 0.89 | DGKA (0.63) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL5930623 | 0.88 | DGKA (0.60) | DGKANAAAALDH1A1HTR2CMGLL | |
| SCHEMBL421653 | 0.88 | NAAA (0.60) | DGKANAAAALDH1A1HTR2CDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461135-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-8066880-B2 | Apparatus for denitrifying wastewater | HOOT AEROBIC SYSTEMS, INC. (US) | 2011-11-29 | — | — | US | claimed |
| US-8039450-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2011-10-18 | — | — | US | claimed |
| US-20090211957-A1 | Apparatus For Denitrifying Wastewater | CORMIER, TROY L. | 2009-08-27 | — | — | US | claimed |
| CN-1378530-A | Process for preparing peroxides using mixed anhydrides | AKZO NOBEL NV (NL) | 2002-11-06 | — | — | CN | claimed |
| US-20260115157-A1 | FORMULATIONS CONTAINING ACETAMINOPHEN AND SULFOALKYL ETHER CYCLODEXTRIN | CYDEX PHARMACEUTICALS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12527755-B2 | Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin | CYDEX PHARMACEUTICALS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20240358544-A1 | METHOD OF TREATING VISION LOSS IN A HUMAN SUBJECT WITH PHOTOREACTIVE COMPOUNDS | KIORA PHARMACEUTICALS PTY LTD (AU) | 2024-10-31 | — | — | US | disclosed |
| CN-118510877-A | Cleaning composition for pretreatment of metal substrates, method for the production thereof and use thereof | 巴斯夫涂料有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-117063124-A | Method for manufacturing flexible printed board | 株式会社钟化 | 2023-11-14 | — | — | CN | disclosed |
| US-20230357451-A1 | ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME | CYDEX PHARMACEUTICALS INC (US) | 2023-11-09 | — | — | US | disclosed |
| CN-116997856-A | Method for manufacturing flexible printed board | 株式会社钟化 | 2023-11-03 | — | — | CN | disclosed |
| US-20060165920-A1 | Image recording sheet and method of image recording | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| CN-1767952-A | Image recording sheet and method of image recording | DAICEL CHEM (JP) | 2006-05-03 | — | — | CN | disclosed |
| CN-1714113-A | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2005-12-28 | — | — | CN | disclosed |
| EP-1591264-A1 | IMAGE RECORDING SHEET AND METHOD OF IMAGE RECORDING | Daicel Chemical Industries, Ltd. (JP) | 2005-11-02 | — | — | EP | disclosed |
| CN-1378530-A | Process for preparing peroxides using mixed anhydrides | AKZO NOBEL NV (NL) | 2002-11-06 | — | — | CN | disclosed |
| US-6288061-B1 | INTERLEUKIN INHIBITORS; ASTHMA, BRONCHODILATOR AGENTS, ANTIALLERGENS | WELFIDE CORPORATION (JP) | 2001-09-11 | — | — | US | disclosed |
| US-4808443-A | COATING THIN FILM ON WET SURFACE RIGHT AFTER PRINTING | SAKATA SHOKAI, LTD. (JP) | 1989-02-28 | — | — | US | disclosed |
| US-4442103-A | ANTIDEPRESSANTS | MERCK & CO., INC. (US) | 1984-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358544-A1 | METHOD OF TREATING VISION LOSS IN A HUMAN SUBJECT WITH PHOTOREACTIVE COMPOUNDS | PDE6C, ALDH1A2, PDE6D | DGKA 3306/4885NAAA 1990/4885ALDH1A1 572/4885 |
| US-20260115157-A1 | FORMULATIONS CONTAINING ACETAMINOPHEN AND SULFOALKYL ETHER CYCLODEXTRIN | CYP2C8, CYP3A43, SULT2A1 | DGKA 4708/4885NAAA 2512/4885ALDH1A1 2123/4885 |
| US-12527755-B2 | Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin | TPMT, GSTP1, ALB | DGKA 4811/4885NAAA 4043/4885ALDH1A1 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.